BRIEF-IX Biopharma Says Entered Exclusive License Agreement With Seelos Therapeutics
BRIEF-IX Biopharma Says Entered Exclusive License Agreement With Seelos Therapeutics
Brief-IX Biophma表示与Seelos治疗公司达成独家许可协议
Nov 24 (Reuters) - IX Biopharma Ltd IXBI.SI :
路透11月24日电-IX Biophma Ltd IXBI.SI：
* ENTERED INTO AN EXCLUSIVE LICENSE AGREEMENT WITH SEELOS THERAPEUTICS
*与SEELOS治疗公司签订独家许可协议
* WILL RECEIVE US$9 MILLION UPFRONT PAYMENT TO BE SATISFIED IN CASH AND SHARES
*将收到900万美元的预付款，以现金和股票支付
* ALSO ELIGIBLE FOR UP TO US$239 MILLION IN MILESTONE PAYMENTS AS PART OF DEAL
*作为交易的一部分，还有资格获得高达2.39亿美元的里程碑付款
Source text for Eikon: ID:nSN4DNx5y Further company coverage: IXBI.SI
Eikon的源文本：ID：nSN4DNx5y进一步的公司报道：IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com；)